WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Ohio judge to rule Monday on whether the state’s abortion ban stands
Now THAT'S a room with a view: Inside the St Regis Abu Dhabi
Four farm silos listed for £200k and they can be converted to a fabulous family home
HK$3.5 billion Hong Kong Palace Museum opens after typhoon delay
College baseball notebook: Conference tournaments to decide NCAA automatic bids and many at
Tale of the state pension underpaid for 20 YEARS: This is Money podcast
You're sure of a warm welcome along the awe
World's biggest bridges revealed after collapse of colossal Baltimore landmark
Travis Kelce downs whiskey shot on slice of bread at Kelce Jam without Taylor Swift
Humiliation for Saudi Arabia as it's 'forced to scale back $1.5trillion plans for 106
Celebrity birthdays for the week of May 26
Why Jimmy Mitchell's happy snap of his family boarding a plane saw him booted from a Jetstar flight